Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection

Takuya Yamamoto1, Rebecca M Lynch2, Rajeev Gautam3

  • 1Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

Related Concept Videos